PD-1 blockade works alone

被引：0
|
作者：
不详
机构：
来源：
NATURE BIOTECHNOLOGY | 2022年 / 40卷 / 07期
关键词：
D O I：
10.1038/s41587-022-01403-1
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：986 / 986
页数：1
相关论文
共 50 条
  • [21] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [22] Toxicities Associated With PD-1/PD-L1 Blockade
    Wang, Daniel Y.
    Johnson, Douglas B.
    Davis, Elizabeth J.
    CANCER JOURNAL, 2018, 24 (01): : 36 - 40
  • [23] PD-1 Blockade in Advanced Adrenocortical Carcinoma
    Raj, Nitya
    Zheng, Youyun
    Kelly, Virginia
    Katz, Seth S.
    Chou, Joanne
    Do, Richard K. G.
    Capanu, Marinela
    Zamarin, Dmitriy
    Saltz, Leonard B.
    Ariyan, Charlotte E.
    Untch, Brian R.
    O'Reilly, Eileen M.
    Gopalan, Anuradha
    Berger, Michael F.
    Olino, Kelly
    Segal, Neil H.
    Reidy-Lagunes, Diane L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (01) : 71 - +
  • [24] DGKA Mediates Resistance to PD-1 Blockade
    Fu, Lingyi
    Li, Sen
    Xiao, WeiWei
    Yu, Kuai
    Li, Shuo
    Yuan, Sujing
    Shen, Jianfei
    Dong, Xingjun
    Fang, Ziqian
    Zhang, Jianeng
    Chen, Siyu
    Li, Wende
    You, Hua
    Xia, Xiaojun
    Kang, Tiebang
    Tan, Jing
    Chen, Gong
    Yang, An-Kui
    Gao, YuanHong
    Zhou, Penghui
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (04) : 371 - 385
  • [25] Desmoplasia is no barrier to PD-1 blockade in melanoma
    David Killock
    Nature Reviews Clinical Oncology, 2018, 15 : 200 - 200
  • [26] Microsatellite Instability as a Biomarker for PD-1 Blockade
    Dudley, Jonathan C.
    Lin, Ming-Tseh
    Le, Dung T.
    Eshleman, James R.
    CLINICAL CANCER RESEARCH, 2016, 22 (04) : 813 - 820
  • [27] Biomarkers of response to PD-1 pathway blockade
    Li, Hanxiao
    van der Merwe, P. Anton
    Sivakumar, Shivan
    BRITISH JOURNAL OF CANCER, 2022, 126 (12) : 1663 - 1675
  • [28] Predicting Tumor Response to PD-1 Blockade
    Ding, Li
    Chen, Feng
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (05): : 477 - 479
  • [29] PD-1 blockade exploiting MMR deficiency
    David Killock
    Nature Reviews Clinical Oncology, 2017, 14 : 459 - 459
  • [30] Combining chemotherapy with PD-1 blockade in NSCLC
    Mathew, Matthen
    Enzler, Thomas
    Shu, Catherine A.
    Rizvi, Naiyer A.
    PHARMACOLOGY & THERAPEUTICS, 2018, 186 : 130 - 137
12345